Does the upcoming U.S. election matter to the cause of access to medicines?
The correct answer is “Yes, but . . .”
The answer is yes, because the U.S. President and members of Congress are enormously influential on access to medicines policy. Clearly, this is true in the U.S., with the prospect of potential changes in 2017 to Medicare drug pricing and discounts to governments on drugs discovered with taxpayer dollars.